INTRODUCTION
Biochemical and morphological experiments have shown the presence of caveolae, cave-like plasma-membrane subdomains, in many cell types including vascular endothelial cells (ECs) [1, 2] . Caveolin-1 is the major protein component of caveolae and is found primarily in two isoforms, caveolin-1α and caveolin-1β, that differ in their N-termini and are derived from alternative translation initiation sites [3] . Caveolin-1 is an integral membrane protein with an unusual hairpin-like conformation ; the N-terminal and C-terminal regions both face the cytosol and are connected by a membrane-embedded hydrophobic domain containing 33 amino acid residues [4] . Caveolin-1 participates in multiple protein-protein interactions that are critical for its various functions. Interactions of caveolin-1 with adjacent caveolin-1 molecules require residues in both the N-terminal and C-terminal domains and result in the oligomerization of caveolin-1 and the formation of a rigid scaffold that maintains the characteristic cave-like morphology [5] [6] [7] . Interactions between caveolin-1 and caveolin-2 in their membrane-embedded domains might also contribute to this structure [8] . In addition to its structural function, caveolin-1 has several important regulatory activities. For example caveolin-1 interacts, via a consensus caveolin-binding motif, with signalling proteins including heterotrimeric G-protein α subunits, protein tyrosine kinases, p21 Ha-ras and EC-specific nitric oxide synthase (' eNOS ') [9] [10] [11] . Interaction with caveolin generally inhibits the signal-transducing activity of the protein [12] . Recent studies suggest that caveolin-1 interacts with chaperones of the immunophilin family to form a soluble complex [13] involved in the transport of cholesterol from the Abbreviation used : ECs, endothelial cells. 1 To whom correspondence should be addressed (e-mail foxp!ccf.org). # O # did not alter the rate of caveolin-1 depalmitoylation but instead decreased the ' on-rate ' of palmitoylation. Together these results show for the first time the modulation of protein palmitoylation by oxidative stress, and suggest a cellular mechanism by which stress might influence caveolin-1-dependent cell activities such as the concentration of signalling proteins and cholesterol trafficking.
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endoplasmic reticulum to the caveolae and subsequently to noncaveolar plasma membranes [14] .
Caveolin-1 is subject to two types of post-translational modification that might be critical for regulating its intracellular activity and localization, namely phosphorylation and palmitoylation. Caveolin-1 was first identified as the major phosphoprotein in Rous-sarcoma-virus-transformed cells [15] . Tyr"% on caveolin-1 was subsequently shown to be a principal target for Src kinase [16] . The functional consequences of caveolin-1 phosphorylation are not yet known but it might drive intracellular relocalization to regions near focal adhesions [17] . Tyrosine phosphorylation of caveolin-1 is stimulated by polypeptide growth factors and by cellular stress, most probably by the activation of p38-mitogen-activated protein kinase [17] . Similarly, treatment of NIH 3T3 cells and ECs with H # O # causes increased Tyr"% phosphorylation [17] [18] [19] . The finding that caveolin-1 is a sensitive target of oxidative stress has been confirmed by functional studies. Smart et al. [20] have shown that the oxidation of caveolar membrane cholesterol causes the translocation of caveolin-1 from the plasma membrane to the Golgi apparatus. In a separate study, treatment of ECs with reactive oxygen species caused a release of caveolin-1 from membranes and also a decrease in the number of caveolae detected by electron microscopy [21] . Oxidative stress might also influence the cellular level of caveolin, as suggested by results showing that oxysterols decrease caveolin-1 mRNA expression in fibroblasts [22] .
Caveolin-1, like many caveolae-resident proteins, is susceptible to modification by acylation. Protein palmitoylation is a posttranslational modification in which palmitic acid, a 16-carbon saturated fatty acid, is attached by an S-ester linkage to the thiol group of specific cysteine residues. Palmitoylation can influence the membrane interactions, protein-protein interactions, localization, conformation and activity of target proteins [23] [24] [25] . Caveolin-1 is triply palmitoylated on cysteine residues at positions 133, 143 and 156 near the C-terminus [26] . Site-directed mutagenesis studies [27] suggest that the palmitoylation of one or more caveolin-1 cysteine residues is required for optimal stability of the oligomeric structures that contribute to caveolar structure [6] and the sequestration of signalling molecules [28] . Caveolin-1 has been implicated in cholesterol transport processes [14] ; the palmitoylation of at least two of the three cysteine residues is required for cholesterol binding, for the formation of soluble caveolin-immunophilin complexes and for the transport of cholesterol from the site of synthesis in the endoplasmic reticulum to caveolae [29] . So far there have been no reports on the regulation of caveolin-1 palmitoylation. Here we provide evidence that oxidative stress decreases the trafficking of newly synthesized caveolin-1 to lipid rafts and that this effect is associated with a decreased rate of caveolin-1 palmitoylation. 
MATERIALS AND METHODS

Materials
Cell culture
Bovine aortic ECs were maintained in DMEM (Dulbecco's modified Eagle's medium) and F12 medium supplemented with 5 % (v\v) fetal bovine serum, 100 i.u.\ml penicillin and 100 µg\ml streptomycin, in a humidified air\CO # (19 : 1) atmosphere. Cells were subjected to H # O # either by the direct addition of a dilute H # O # solution, followed by incubation for 15-30 min at 37 mC, or by the addition of glucose oxidase (up to 300 ng\ml for 1 h) to the medium, followed by incubation for 60 min at 37 mC.
Caveolin-1 localization in ECs by immunofluorescence
Subconfluent ECs were grown on glass chamber slides (Falcon ; Becton-Dickinson, Franklin Lakes, NJ, U.S.A.). The cells were washed with PBS, fixed for 20 min with 3.7 % (v\v) formaldehyde in PBS, then washed three times with PBS (all treatments at room temperature, about 23 mC). The cells were permeabilized for 10 min with 0.1 % (v\v) Triton X-100 and washed. To decrease non-specific binding of antibody, ECs were preincubated with 3 % (v\v) goat serum (Gibco, Grand Island, NY, U.S.A.) in PBS for 20 min. The cells then were incubated for 60 min with the primary anti-(caveolin-1) antibody (1 µg\ml) in a solution containing 1.5 % (v\v) goat serum in PBS. After three washes with PBS and a 5 min incubation with 3 % (v\v) non-immune goat serum, the cells were incubated for 45 min with biotinylated goat anti-rabbit antibody (dilution 1 : 1000 ; Vector Laboratories, Burlingame, CA, U.S.A.) in 1.5 % (v\v) goat serum. After being washed, cells were incubated for 10 min with Texas Red-avidin (diluted 1 : 1000 in PBS), washed and placed in mounting medium (Vectashield). No reactivity was observed when the primary antibody was replaced with non-immune rabbit IgG (1 µg\ml) or with buffer, or when both primary and secondary antibodies were replaced by buffer. Autofluorescence was not detectable in ECs under our experimental conditions.
Analysis of caveolin-1 in lipid rafts by sucrose-gradient fractionation
A membrane fraction enriched in lipid rafts was isolated with a discontinuous sucrose gradient [30] . Confluent ECs in two 10 cmdiameter dishes were rinsed twice with PBS and scraped into 2 ml of buffer containing Na # CO $ (500 mM), pH 11, aprotinin (20 µg\ml) and leupeptin (5 µg\ml). The cells were homogenized by ten strokes in a Dounce homogenizer followed by sonication for 1 min with a bath sonicator (Laboratory Supplies, Hicksville, NY, U.S.A.). In experiments requiring the immunoprecipitation of caveolin-1, the cells were lysed in MES-buffered saline [25 mM Mes (pH 6.5)\0.15 M NaCl] containing 1 % (v\v) Triton X-100, aprotinin and leupeptin [9, 20] ; the lysate was subjected to Dounce homogenization. For both lysis procedures, the homogenate was adjusted to 42.5 % (w\v) sucrose by the addition of 2 ml of 85 % sucrose in MES-buffered saline. The mixture was overlaid with 5 ml of 30 % (w\v) sucrose solution followed by 3 ml of 5 % (w\v) sucrose, both in MES-buffered saline. After centrifugation at 260 000 g for 18 h, 1 ml fractions were removed from the top. The caveolin-1-enriched membrane fraction was at the 5-30 % sucrose interface in fraction 4.
Determination of caveolin-1 synthesis by metabolic labelling with [ 35 S]methionine
Caveolin-1 synthesis de no o by ECs was determined by metabolic labelling. Confluent ECs were incubated with [$&S]methionine (60 µCi\ml) in thiol-free medium for 20-30 min. The cells were washed twice with PBS and lysed for 90 min at 4 mC in 0.6 ml of buffer containing 50 mM Hepes, pH 7.4, 150 mM NaCl, 1 mM EDTA, 2.5 mM MgCl # , 0.5 % sodium deoxycholate, 1 % (v\v) Nonidet P40, 20 µg\ml aprotinin and 5 µg\ml leupeptin. The lysate was collected by scraping and was cleared by centrifugation at 16 000 g for 3 min. SDS (0.1 % final concentration) was added to the supernatant and the mixture was incubated first with rabbit polyclonal anti-(caveolin-1) antibody for 90 min, then with Protein A-Sepharose for 60 min. Control cell lysates were immunoprecipitated with rabbit non-immune IgG. Immunoprecipitated complexes were collected by low-speed centrifugation, washed three times with the lysate buffer and then analysed by SDS\PAGE [15 % (w\v) polyacrylamide]. The gels were stained with Coomassie Blue dye and radiolabel was detected by autoradiography.
Immunoblot analysis of caveolin-1 and phosphorylated caveolin-1
Proteins from EC lysates or raft-enriched fractions were separated by SDS\PAGE [15 % (w\v) polyacrylamide] and transferred to nitrocellulose. Caveolin-1 was detected by immunoblot analysis by using rabbit polyclonal antibody as primary antibody and peroxidase-conjugated secondary antibody. Phosphorylation on caveolin-1 residue Tyr"% was detected with monoclonal anti-phosphocaveolin-1. Blots were developed by enhanced chemiluminescence with ECL2 and hyperfilm-ECL2 (Amersham, Arlington Heights, IL, U.S.A.), and quantified densitometrically with a flatbed scanner and the N. I. H. Image 
Determination of caveolin-1 palmitoylation in ECs by metabolic labelling with [ 3 H]palmitate
Caveolin-1 palmitoylation was measured essentially as described [31] . Confluent ECs in 10 cm dishes were washed with serum-free DMEM and then incubated for 2 h in the same medium. ECs were radiolabelled for 15-30 min by incubation with [$H]palmitic acid (250 µCi\ml) in serum-free medium containing 3.5 mg\ml fatty-acid-free BSA ; the cells were then lysed. To examine the palmitoylation of total cellular protein, an aliquot was subjected to SDS\PAGE [12 % (w\v) polyacrylamide] under non-reducing conditions. Caveolin-1 was immunoprecipitated from the remainder of the lysate by using rabbit polyclonal anti-(caveolin-1) antibody and subjected to SDS\PAGE as described above. The gels were stained with Coomassie Blue dye and radiolabel was determined by fluorography after a 3-6-week exposure. The identity of immunoprecipitated proteins had been confirmed previously by mass spectrometric analysis [31] . Fragment sequences from the upper band were identical with sequences in bovine caveolin-1α. The lower band contained fragment sequences identical with bovine caveolin-1β and also sequences consistent with the presumptive sequence of bovine caveolin-2 (based on homology with human caveolin-2). The observed palmitoylation of the lower band was most probably due to caveolin-1β because caveolin-2 does not contain the conserved C-terminal cysteine residues palmitoylated in other caveolin types (and because the palmitoylation of caveolin-2 has not been reported).
RESULTS
Effect of H 2 O 2 on subcellular localization of caveolin-1 in ECs
We were interested in the effect of H # O # on the intracellular localization of caveolin-1 because others have shown that H # O # induces caveolin-1 phosphorylation [17] [18] [19] and because agents associated with oxidative stress, namely oxysterols and superoxide, alter the expression and membrane association of caveolin-1 [21, 22] .We examined the effect of H # O # on the subcellular localization of caveolin permeabilized ; caveolin-1 was detected with polyclonal rabbit anti-(human caveolin-1) antibody followed by biotinylated antirabbit IgG and Texas Red-avidin. The strongest caveolin-1 signal was seen in distinct plasma membrane regions and also in most cellular extensions ( Figure 1A, left panel) Figure 1B ). Neither the addition of H # O # as a bolus nor the addition of a H # O # -generating system containing glucose oxidase and glucose caused a significant shift of caveolin-1 from caveolar (fraction 4) to non-caveolar (fractions 9-12) fractions. Taken together, these results suggest that the exposure of ECs to H # O # does not influence the subcellular localization of caveolin-1. However, each of these localization methods detects the entire cellular pool of caveolin-1 and not specific subcellular pools such as newly synthesized caveolin-1. This pool is of special interest because we have shown previously that newly synthesized caveolin-1 is particularly susceptible to palmitoylation [31] . Figure 2B ). The absence of the minor (β) isoform of caveolin-1 in immunoblot assays but its presence in metabolic labelling studies might reflect differential sensitivities of the antibody towards the α and β isoforms under the two assay conditions. The observed decrease in newly synthesized caveolin-1 in caveolae was not due to inhibition of de no o synthesis of caveolin-1 by H # O # . This result was shown in an experiment in which unfractionated lysates from metabolically labelled cells were subjected to immunoprecipitation of caveolin-1. H # O # did not inhibit the incorporation of [$&S]methionine into total cellular caveolin-1 ( Figure 2C) ; cycloheximide included as a control effectively inhibited caveolin-1 synthesis. Taken together, these results show that oxidative stress does not affect subcellular localization of pre-existing caveolin-1, which represents most of the caveolin-1 detected in the cell by methods based on mass (i.e. not those based on isotope labelling), but instead it impairs the targeting of newly synthesized caveolin-1 to caveolar domains.
Effect of H 2 O 2 on caveolin-1 phosphorylation
induces the phosphorylation of caveolin-1 on Tyr"% [18, 19] . In other studies, caveolin-1 phosphorylation has been shown to alter trafficking and to cause intracellular relocalization to regions near focal adhesions [17] . We examined whether the impaired trafficking of caveolin-1 to caveolae by treatment with H # O # was associated with caveolin-1 phosphorylation. ECs were incubated (Figure 3) . However, concentrations up to 500 µM had no effect. Activated Na $ VO % was used as a positive control for caveolin-1 phosphorylation on Tyr"%. To verify that the observed phosphorylation was due to caveolin-1, a separate experiment was done in which caveolin-1 from cell lysates was first immunoprecipitated with polyclonal anti-(caveolin-1), then subjected to immunoblotting with antiphosphocaveolin monoclonal antibody. Essentially identical results were obtained by this method (results not shown). We also considered the possibility that low concentrations of H # O # could stimulate the phosphorylation of caveolin-1 present in specific cellular pools ; however, no increase in Tyr"% phosphorylation was observed in caveolae-enriched fractions isolated by sucrose fractionation (results not shown). The finding that low levels of H # O # inhibit caveolin-1 trafficking to caveolae but do not induce caveolin-1 phosphorylation suggests that the H # O # -mediated alteration in trafficking is not mediated by Tyr"% phosphorylation.
H 2 O 2 inhibits palmitoylation of caveolin-1 in endothelial cells
Protein targeting to caveolae often depends on the acylation state of the protein, and particularly palmitoylation [28, 34] . To determine whether oxidative stress altered caveolin-1 palmitoylation, ECs were incubated for 20 min with [$H]-palmitate in the presence of H # O # . We had previously shown that radiolabelling was due to the covalent modification of caveolin-1 by palmitate, as shown by the release of hydroxylamine and by a TLC analysis of fatty acid released by alkaline hydrolysis [31] . total of both isoforms) was seen at approx. 100 µM H # O # and near-maximal inhibition (approx. 90 %) at 500 µM H # O # ( Figure  4A) . Analysis of the total cell lysate not subjected to immunoprecipitation showed that H # O # did not significantly decrease the labelling of most other detectable proteins, suggesting that the inhibition of [$H]palmitate incorporation was specific with regard to target protein ( Figure 4B ) and that the inhibition of caveolin-1 A decreased incorporation of palmitate into caveolin-1 could be due to a combination of a decreased rate of palmitoylation and an increased rate of depalmitoylation. A pulse-chase experiment was performed to determine which of these processes were modified by H # O # . ECs were preincubated with [$H]-palmitate for 30 min ; the exogenous radiolabel was then removed and chased for up to 2 h with medium containing fetal bovine serum to saturate the system with unlabelled fatty acid and cycloheximide to block the de no o synthesis of caveolin-1. As reported previously, the turnover of palmitate in caveolin-1 is extremely slow, in fact undetectable even after a chase interval of 24 h [31] . H # O # at 200 µM ( Figure 5 ) or 500 µM (results not shown) did not alter the release of [$H]palmitate from either caveolin-1 isoform, suggesting that the H # O # -mediated decrease in the amount of [$H]palmitate incorporated into caveolin-1 was not due to increased depalmitoylation but rather to a decrease in the rate of palmitoylation itself.
DISCUSSION
Agonist-induced alteration of [$H]palmitate incorporation into several proteins, including the β # -adrenergic receptor [36] , Gprotein α-subunits [24] and EC-specific nitric oxide synthase [23] , has been investigated in detail. In contrast, much less is known about other types of regulation of protein palmitoylation. Inhibition of palmitoylation of several proteins by non-physiological agents has been reported, such as inhibition of p21 Ha -ras and p21 N -ras by cerulenin [37] , inhibition of glycoprotein palmitoylation by homologues of tunicamycin [38] and inhibition of Fyn palmitoylation by 2-bromopalmitate [39] . There is little information on physiological inhibitors of protein palmitoylation. For example, arachidonic and eicosapentaenoic acid inhibit Fyn palmitoylation in COS-1 cells and nitric oxide inhibits palmitoylation of GAP-43 and SNAP-25 in neuronal cells, with functional consequences for neurite growth [40] . In a more recent study, nitric oxide decreased the agonist-stimulated incorporation of [$H]palmitate into G s α and the β # -adrenergic receptor, thereby decreasing functional coupling between the receptor and its downstream G-protein target [41] . The mechanism underlying the inhibition of palmitoylation by nitric oxide is not known ; regulation of the activity of acylating and deacylating enzymes and modification of cysteine thiols on target proteins have been suggested [40] .
The mechanism by which H # O # inhibits caveolin-1 palmitoylation is not yet known. We have considered the possibility that H # O # modifies one or more amino acids in caveolin-1, which decreases the subsequent incorporation of palmitate. Such modifications can be either ' same-site ', in which the interference is by competition for a cysteine residue, or ' other-site ', in which interference is due to local steric hindrance or to global changes in tertiary structure. In the bradykinin B2 receptor [42] , palmitoylation of a cysteine residue and phosphorylation of a nearby tyrosine residue (four residues away) are mutually exclusive. We considered a similar mechanism for caveolin-1 because H # O # stimulates tyrosine phosphorylation and blocks palmitoylation. Although Tyr"% is far in the sequence from the three palmitoylated cysteine residues near the C-terminus of the protein, the hairpin-like structure proposed for caveolin-1 might bring these residues near to each other. Our results confirm that H # O # induces Tyr"% phosphorylation of caveolin-1 in ECs ; however, it is not likely to inhibit caveolin-1 palmitoylation because the concentration dependences are discrepant. Other protein modifications caused by conditions of oxidative stress include proline hydroxylation [43] , oxo-histidine formation [44] and glutathionylation of cysteine [45] . It is tempting to speculate that proline hydroxylation might be involved in view of the proximity of Pro"$# and Pro"&) to Cys"$$ and Cys"&' in caveolin-1. However, attempts to use trypsin digestion and analysis by capillary liquid chromatography-electrospray MS to determine the amino acid modification of caveolin-1 have been unsuccessful. In fact, the entire palmitoylated region is undetectable, possibly owing to its hydrophobicity and low volatility (results not shown).
Given that palmitoylation enhances protein trafficking to caveolae [28, 46] , it is likely that the inhibition in palmitoylation of caveolin-1 mediated by H # O # is responsible for the observed decrease in targeting to membrane rafts. However, it is also possible that the converse mechanism is important, namely that the observed decrease in palmitoylation is a consequence (not the cause) of impaired targeting of caveolin-1 to membrane rafts in the presence of H # O # . Indeed, with few exceptions [47] , protein palmitoylation occurs primarily at the plasma membrane, where palmitoyl transferase activity is concentrated [48, 49] . Newly synthesized caveolin-1 might be incorporated into detergent-resistant membranes in the Golgi apparatus [50] . We have previously shown that inhibition of trafficking of newly synthesized caveolin-1 to the plasma membrane by Brefeldin A or monensin results in a marked decrease in caveolin-1 palmitoylation, indicating that caveolin-1 palmitoylation occurs after the trans-Golgi compartment [31] . Thus we cannot exclude the possibility that oxidative stress, by an unknown mechanism, alters the trafficking of nascent caveolin-1, which therefore does not reach its membrane site of palmitate incorporation.
The cellular consequences of the inhibition by oxidative stress of caveolin-1 palmitoylation and trafficking are not known.
Because our results suggest that the inhibition by oxidative stress is restricted to newly made caveolin-1, it is likely that the stress will primarily alter processes requiring the synthesis of caveolin-1 de no o. Alternatively, chronic exposure of cells and tissues to oxidative stress might alter the palmitoylation state and cellular localization of most of the protein. Major functions of caveolin-1 require palmitoylation, for example caveolar organization through oligomerization, the regulation of signal transduction, and cholesterol transport [27] [28] [29] ; however, the specific role of newly synthesized caveolin-1 in these processes has not been investigated. Previous studies on the role of caveolin-1 palmitoylation have used transfection with palmitoylationdefective mutants. The inhibition of caveolin-1 palmitoylation by H # O # could provide an additional tool for investigating these activities and in particular the specific functions of caveolin-1 that require its synthesis de no o. 
